Eugéniu Banu - Concepedia

Author

Eugéniu Banu

Hôpital Européen Georges-Pompidou

Also Known As

Banu, Eugeniu, E Banu, E. Banu, E.B. Banu, EUGENIU BANU, Eugeniu Banu, Eugéniu Banu

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Hôpital Européen Georges-Pompidou Université Paris Cité Délégation Paris 5 Assistance Publique – Hôpitaux de Paris Hôpital Européen

About

Eugéniu Banu is an author at Hôpital Européen Georges-Pompidou specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	644
2	Pathology	3	3	182
3	Health Sciences	1	1	12
4	Immunology	1	1	102
5	Pharmacology	1	1	106

Eugéniu Banu

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Multicenter Study of a Frozen Glove to Prevent Docetaxel-Induced Onycholysis and Cutaneous Toxicity of the Hand Florian Scotté, Jean‐Marc Tourani, Eugéniu Banu, Journal of Clinical Oncology	2005	193
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2 Stéphane Oudard, Stéphane Culine, Yann Vano, European Journal of Cancer UrologyMetastatic Urothelial CarcinomaPhase Ii TrialGenitourinary CancerMedicine	2014	141
Multicenter Randomized Phase II Study of Two Schedules of Docetaxel, Estramustine, and Prednisone Versus Mitoxantrone Plus Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer Stéphane Oudard, Eugéniu Banu, Philippe Beuzeboc, Journal of Clinical Oncology	2005	141
Metastatic Renal Carcinoma: Evaluation of Antiangiogenic Therapy with Dynamic Contrast-enhanced CT Laure Fournier, Stéphane Oudard, R. Thiam, Radiology	2010	130
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations Georgios Tsaousis, Eirini Papadopoulou, Angela Apessos, BMC Cancer	2019	127
Phase II Study of Lonidamine and Diazepam in the Treatment of Recurrent Glioblastoma Multiforme Stéphane Oudard, Eugéniu Banu, F. Fauchon, Journal of Neuro-Oncology	2003	116
Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy Dominique Helley, Eugéniu Banu, Abdelkader Bouziane, European Urology UrologyMedicineDocetaxel-based ChemotherapyPharmacologyPlatelet Microparticles	2008	106
Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot Florian Scotté, Eugéniu Banu, Jacques Médioni, Cancer	2008	102
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Cancer Immunology Immunotherapy VaccinationCancer ImmunosurveillanceGenitourinary CancerImmunologyTumor Immunity	2010	102
Multiple Lung Cancers Prognosis: What About Histology? Marc Riquet, Aurélie Cazes, Karel Pfeuty, The Annals of Thoracic Surgery MedicineMultiple Pulmonary NoduleSurgical PathologyPathologyCancer Prognosis	2008	99

Page 1